Expertise in
8
conditions

Dr. Anca Bulgaru

Hematology
Smilow Cancer Hospital-Waterford
230 Waterford Parkway S, 
Waterford, CT 
Offers Telehealth
Expertise in
8
conditions
Smilow Cancer Hospital-Waterford
230 Waterford Parkway S, 
Waterford, CT 

Overview

Anca Bulgaru is a Hematologist practicing medicine in Waterford, Connecticut.

Dr. Bulgaru is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Muscle Invasive Bladder Cancer, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 3 clinical trials.

Specialties

Hematology

Licenses

Internal Medicine in CT

Hospital Affiliations

Westerly Hospital
Yale-New Haven Hospital
Lawrence & Memorial Hospital
William W Backus Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Smilow Cancer Hospital-Waterford
230 Waterford Parkway S, Waterford, CT 06385

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
Enrollment Status: Active_not_recruiting
Publish Date: August 18, 2026
Intervention Type: Drug, Other
Study Drug: Ribociclib
Study Phase: Phase 3
A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer
A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Tamoxifen, Prophylactic Loperamide
Study Phase: Phase 2
COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drugs: Ribociclib, Letrozole, Goserelin, Leuprolide
Study Phase: Phase 3
View 2 Less Clinical Trials

1 Total Publications

Decreasing the Interval Wait Times for Screening Mammogram Results Using the "Reflex Testing" Algorithm.
Decreasing the Interval Wait Times for Screening Mammogram Results Using the "Reflex Testing" Algorithm.
Journal: Journal of breast imaging
Published: September 29, 2021
Similar Doctors
Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Rhode Island Hospital

593 Eddy St, 
Providence, RI 
 (50.1 miles away)
401-444-5435
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Adam Olszewski is a Hematologist practicing medicine in Providence, Rhode Island. Dr. Olszewski is highly rated in 26 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Splenectomy, and Bone Marrow Aspiration.

Expertise in
22
conditions
Dr. Harriet Kluger
Hematology | Oncology
Expertise in
22
conditions
Dr. Harriet Kluger
Hematology | Oncology
Referral may be required

Smilow Cancer Hospital

35 Park St, # Np8, 
New Haven, CT 
 (39.6 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Harriet Kluger is a Hematologist and an Oncologist practicing medicine in New Haven, Connecticut. Dr. Kluger is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Brain Tumor, and Nephrectomy.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

UConn John Dempsey Hospital

263 Farmington Ave, 
Farmington, CT 
 (40.7 miles away)
860-679-2100
Languages Spoken:
English
See accepted insurances

Biree Andemariam is a Hematologist practicing medicine in Farmington, Connecticut. Dr. Andemariam is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Frequently Asked Questions about Dr. Anca Bulgaru

How do I make an appointment with Dr. Anca Bulgaru?

You can book an appointment with Dr. Anca Bulgaru by calling their office at 860-444-3744. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Anca Bulgaru a top-rated expert for Large-Cell Immunoblastic Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anca Bulgaru is classified as an Distinguished expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Anca Bulgaru specialize in?

While Dr. Anca Bulgaru is a Hematology, they have specific expertise in Large-Cell Immunoblastic Lymphoma, Muscle Invasive Bladder Cancer, and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Anca Bulgaru participate in research or clinical trials?

Yes. Dr. Anca Bulgaru has published 1 articles and abstracts on conditions like Large-Cell Immunoblastic Lymphoma. You can view a list of Dr. Anca Bulgaru's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Anca Bulgaru accept my insurance?

Dr. Anca Bulgaru accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 860-444-3744 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bulgaru's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile